File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia

TitleFirst evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia
Authors
Issue Date2010
Citation
Molecular Neurodegeneration, 2010, v. 5, n. 1 How to Cite?
AbstractBackground: The pathogenesis of HIV-associated dementia (HAD) is poorly understood. To date, detailed proteomic fingerprinting directly from autopsied brain tissues of HAD and HIV non-dementia patients has not been performed. Result: Here, we have analyzed total proteins from the frontal cortex of 9 HAD and 5 HIV non-dementia patients. Using 2-Dimensional differential in-gel electrophoresis (2-DIGE) to analyze the brain tissue proteome, 76 differentially expressed proteins (p < 0.05; fold change>1.25) were identified between HAD and HIV non-dementia patients, of which 36 protein spots (based on 3D appearance of spots on the images) were chosen for the mass spectrometry analysis. The large majority of identified proteins were represented in the energy metabolic (mitochondria) and signal transduction pathways. Furthermore, over 90% of the protein candidates are common to both HAD and other non-viral neurodegenerative disease, such as Alzheimer's disease. The data was further validated using specific antibodies to 4 proteins (CA2, GS, CKMT and CRMP2) by western blot (WB) in the same samples used for 2D-DIGE, with additional confirmation by immunohistochemitsry (IHC) using frontal lobe tissue from different HAD and HIV+ non-dementia patients. The validation for all 4 antibodies by WB and IHC was in concordance with the DIGE results, lending further credence to the current findings. Conclusion: These results suggest not only convergent pathogenetic pathways for the two diseases but also the possibility of increased Alzheimer's disease (AD) susceptibility in HAD patients whose life expectancy has been significantly increased by highly active antiretroviral therapy. © 2010 Zhou et al; licensee BioMed Central Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/207044

 

DC FieldValueLanguage
dc.contributor.authorZhou, Li-
dc.contributor.authorDiefenbach, Eve-
dc.contributor.authorCrossett, Ben-
dc.contributor.authorTran, Sieu L.-
dc.contributor.authorNg, Thomas-
dc.contributor.authorRizos, Helen-
dc.contributor.authorRua, Rejane-
dc.contributor.authorWang, Bin-
dc.contributor.authorKapur, Amit-
dc.contributor.authorGandhi, Kaushal S.-
dc.contributor.authorBrew, Bruce James-
dc.contributor.authorSaksena, Nitin Kumar-
dc.date.accessioned2014-12-09T04:31:17Z-
dc.date.available2014-12-09T04:31:17Z-
dc.date.issued2010-
dc.identifier.citationMolecular Neurodegeneration, 2010, v. 5, n. 1-
dc.identifier.urihttp://hdl.handle.net/10722/207044-
dc.description.abstractBackground: The pathogenesis of HIV-associated dementia (HAD) is poorly understood. To date, detailed proteomic fingerprinting directly from autopsied brain tissues of HAD and HIV non-dementia patients has not been performed. Result: Here, we have analyzed total proteins from the frontal cortex of 9 HAD and 5 HIV non-dementia patients. Using 2-Dimensional differential in-gel electrophoresis (2-DIGE) to analyze the brain tissue proteome, 76 differentially expressed proteins (p < 0.05; fold change>1.25) were identified between HAD and HIV non-dementia patients, of which 36 protein spots (based on 3D appearance of spots on the images) were chosen for the mass spectrometry analysis. The large majority of identified proteins were represented in the energy metabolic (mitochondria) and signal transduction pathways. Furthermore, over 90% of the protein candidates are common to both HAD and other non-viral neurodegenerative disease, such as Alzheimer's disease. The data was further validated using specific antibodies to 4 proteins (CA2, GS, CKMT and CRMP2) by western blot (WB) in the same samples used for 2D-DIGE, with additional confirmation by immunohistochemitsry (IHC) using frontal lobe tissue from different HAD and HIV+ non-dementia patients. The validation for all 4 antibodies by WB and IHC was in concordance with the DIGE results, lending further credence to the current findings. Conclusion: These results suggest not only convergent pathogenetic pathways for the two diseases but also the possibility of increased Alzheimer's disease (AD) susceptibility in HAD patients whose life expectancy has been significantly increased by highly active antiretroviral therapy. © 2010 Zhou et al; licensee BioMed Central Ltd.-
dc.languageeng-
dc.relation.ispartofMolecular Neurodegeneration-
dc.titleFirst evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1186/1750-1326-5-27-
dc.identifier.scopuseid_2-s2.0-77955676756-
dc.identifier.volume5-
dc.identifier.issue1-
dc.identifier.eissn1750-1326-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats